ID15917A - METHODS FOR OBLIGATION OF LARGE COLUMN TUMORS - Google Patents

METHODS FOR OBLIGATION OF LARGE COLUMN TUMORS

Info

Publication number
ID15917A
ID15917A IDP970182A ID970182A ID15917A ID 15917 A ID15917 A ID 15917A ID P970182 A IDP970182 A ID P970182A ID 970182 A ID970182 A ID 970182A ID 15917 A ID15917 A ID 15917A
Authority
ID
Indonesia
Prior art keywords
obligation
methods
large column
tumors
column tumors
Prior art date
Application number
IDP970182A
Other languages
Indonesian (id)
Inventor
Maria Luisa Brandi
Francesco Tonelli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID15917A publication Critical patent/ID15917A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
IDP970182A 1996-01-29 1997-01-22 METHODS FOR OBLIGATION OF LARGE COLUMN TUMORS ID15917A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors

Publications (1)

Publication Number Publication Date
ID15917A true ID15917A (en) 1997-08-21

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970182A ID15917A (en) 1996-01-29 1997-01-22 METHODS FOR OBLIGATION OF LARGE COLUMN TUMORS

Country Status (19)

Country Link
EP (1) EP0921799A4 (en)
JP (1) JP2000503994A (en)
KR (1) KR19990082054A (en)
CN (1) CN1209745A (en)
AR (1) AR010978A1 (en)
AU (1) AU707892B2 (en)
BR (1) BR9700778A (en)
CO (1) CO4761062A1 (en)
CZ (1) CZ235498A3 (en)
EA (1) EA001104B1 (en)
ID (1) ID15917A (en)
IL (1) IL125521A (en)
MX (1) MX9806036A (en)
NO (1) NO983451L (en)
NZ (1) NZ331105A (en)
PL (1) PL328147A1 (en)
TW (1) TW446560B (en)
WO (1) WO1997026877A1 (en)
YU (1) YU2397A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
ES2179063T3 (en) * 1993-10-15 2003-01-16 Lilly Co Eli PROCEDURES TO TREAT RESISTANT NEOPLASMS.
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
CN1209745A (en) 1999-03-03
NZ331105A (en) 2000-06-23
WO1997026877A1 (en) 1997-07-31
EP0921799A1 (en) 1999-06-16
CZ235498A3 (en) 1999-02-17
MX9806036A (en) 1998-11-29
IL125521A0 (en) 1999-03-12
TW446560B (en) 2001-07-21
IL125521A (en) 2001-11-25
EA199800677A1 (en) 1999-02-25
NO983451D0 (en) 1998-07-27
EP0921799A4 (en) 2002-03-13
JP2000503994A (en) 2000-04-04
AU707892B2 (en) 1999-07-22
NO983451L (en) 1998-07-27
AR010978A1 (en) 2000-08-02
BR9700778A (en) 1998-10-06
YU2397A (en) 1999-11-22
AU2123997A (en) 1997-08-20
EA001104B1 (en) 2000-10-30
KR19990082054A (en) 1999-11-15
CO4761062A1 (en) 1999-04-27
PL328147A1 (en) 1999-01-18

Similar Documents

Publication Publication Date Title
DE69735643D1 (en) IL12 for gene therapy of tumors
NO20005864D0 (en) Quinasols for the treatment of brain tumor
NO971015L (en) Compounds and Methods for the Treatment of Cancer
NO994069D0 (en) Compounds for the Prostate Cancer Immunotherapy and Method of Use
DE69713295T2 (en) AZABICYCLISHE CARBANIUMSAUREESTER FOR THERAPEUTIC USE
ID19886A (en) COMBINED THERAPY FOR OSTEOPOROSIS
NO991955L (en) Process for the treatment of hydrocarbons
NO984431L (en) Procedure for treating pain
ATE239509T1 (en) CONJUGATES FOR THE TREATMENT OF PROSTATE CANCER
ID18679A (en) USE OF FURTHER THERAPY
IS5035A (en) Methods for the prevention of breast cancer
NO986177D0 (en) Method of Preparation of Therapeutic DNA
NO983090D0 (en) Therapeutic compounds
NO984446D0 (en) Procedure for treating pain
DE69735018D1 (en) Interstitial sector arrangement
FI941936A (en) column shoe
DE59702725D1 (en) SIGNAL COLUMN
ID15917A (en) METHODS FOR OBLIGATION OF LARGE COLUMN TUMORS
ATE176738T1 (en) COMBINATION SYSTEM FOR ACCOMMODATION OF CASE-PACKED COMPACT DISCS
IT1285594B1 (en) COLLIMATOR FOR RADIOTHERAPY
ID20291A (en) SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERS
DE69722350D1 (en) Rotating bed for tanning
FI970717A0 (en) Methods for inhibiting uterine cancer
DE59710651D1 (en) sound therapy
FI95164C (en) Column Shoe